HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

Rapper and “international superstar” Nicki Minaj, who just released her second consecutive No. 1 album, inks a fragrance deal with Give Back Brands, the marketer of last year’s smash Justin Bieber Someday scent. FDA issues guidance for nanotechnology in cosmetics. News in brief.

You may also be interested in...



Elizabeth Arden Picks Up Justin Bieber’s Girlfriend In Time For Debut

Elizabeth Arden acquires the Justin Bieber fragrance franchise, including last year’s top-selling prestige launch Someday and the imminent Girlfriend follow-up, from Give Back Brands for an undisclosed sum. Rights to Nicki Minaj fragrances also change hands in the deal.

Joyous Tidings: Holiday Fragrance Sales To Cap Strong Year

Despite a tough economy, U.S. fragrance sales are up in 2011 going into the critical holiday season, outpacing the overall beauty market for the first time in over a decade. Analysts at the Fragrance Foundation’s Nov. 17 State of the Industry event speculate on why.

Stockwatch: Earnings Season Catches An Early Cold As Coronavirus Sweeps In

As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.

 

 

UsernamePublicRestriction

Register

RS018062

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel